Inventor · disambiguated record
Arto Karjalainen
Also filed as: KARJALAINEN ARTO · KARJALAINEN ARTO J · KARJALAINEN ARTO JOHANNES
41 granted patents·829 citations·filing 1979–2006
98Inventor score
Top patents by PatentIndex Score
41 records- 0195US5491173ATri-phenyl alkene derivatives and their preparation and useORION YHTYMAE OY·Filed 1994·Granted Feb 13, 1996·95 cites·12 claims
- 0295US4996225ATri-phenyl alkane derivatives and their oestrogenic, anti-oestrogenic and progestanic usesFARMOS GROUP LTD·Filed 1989·Granted Feb 26, 1991·84 cites·7 claims
- 0395US4696949ANovel tri-phenyl alkane and alkene derivatives and their preparation and useFARMOS GROUP LTD·Filed 1986·Granted Sep 29, 1987·107 cites·7 claims
- 0494US4544664AAntihypertensive substituted imidazole derivativesFARMOS GROUP LTD·Filed 1982·Granted Oct 1, 1985·50 cites·12 claims
- 0592US4443466A4-Benzyl- and 4-benzoyl-substituted imidazole derivatives and use as medicamentsFARMOS OY·Filed 1981·Granted Apr 17, 1984·48 cites·141 claims
- 0688US6875775B2Triphenylalkene derivatives and their use as selective estrogen receptor modulatorsHORMOS MEDICAL OY LTD·Filed 2003·Granted Apr 5, 2005·31 cites·8 claims
- 0785US4910214AOptical isomer of an imidazole derivative medetomidine as an alpha-2-receptor agonistFARMOS OY·Filed 1988·Granted Mar 20, 1990·46 cites·4 claims
- 0880US4670455AMethod of bringing about sedation and/or analgesia in a mammalFARMOS OY·Filed 1985·Granted Jun 2, 1987·35 cites·2 claims
- 0979US6388090B2Imidazole derivativesORION CORP·Filed 2001·Granted May 14, 2002·12 cites·23 claims
- 1079US5098923AAromatase inhibiting 4(5)-imidazolesFARMOS OY·Filed 1990·Granted Mar 24, 1992·40 cites·17 claims
- 1177US7728147B2Detomidine hydrochloride crystallization methodORION CORP·Filed 2006·Granted Jun 1, 2010·2 cites·15 claims
- 1276US4689339A4-dihydroinden-2-yl-, 4-tetrahydronaphth-2-yl-, and 4-dihydrobenzofuran-2-ylimidazoles, useful to block α2 -adrenergic receptorsFARMOS OY·Filed 1985·Granted Aug 25, 1987·22 cites·28 claims
- 1372US5438067AMedetomidine preparations for transdermal administrationORION YHTYMAE OY·Filed 1993·Granted Aug 1, 1995·25 cites·17 claims
- 1472US4275072A2,6-Dichlorophenyl-substituted amino-imidazole derivatives and use as hypertensive agentsFARMOS GROUP LTD·Filed 1979·Granted Jun 23, 1981·6 cites·12 claims
- 1571US4826864ASubstituted imidazole derivatives useful as antihypertensive or antithromtic agent or divreticFARMOS GROUP LTD·Filed 1988·Granted May 2, 1989·12 cites·4 claims
- 1671US4639464AAntihypertensive substituted imidazole derivativesFARMOS GROUP LTD·Filed 1985·Granted Jan 27, 1987·13 cites·18 claims
- 1770US4333947ASubstituted imidazoles and their useFARMOS OY·Filed 1981·Granted Jun 8, 1982·8 cites·23 claims
- 1869US7482340B2Pyridine derivatives useful for inhibiting sodium/calcium exchange systemORION CORP·Filed 2004·Granted Jan 27, 2009·7 cites·7 claims
- 1969US5304569ACompositions and their use in lowering intraocular pressureORION YHTYMAE OY·Filed 1990·Granted Apr 19, 1994·25 cites·5 claims
- 2069US4514412ASubstituted imidazole derivatives and their use as anti-thrombosis agentsFARMOS OY·Filed 1982·Granted Apr 30, 1985·9 cites·29 claims
- 2167US5703109ASelective aromatase inhibiting compoundsORION YHTYMAE OY·Filed 1993·Granted Dec 30, 1997·20 cites·16 claims
- 2263US4517198ADiuretic imidazole derivativesFARMOS GROUP LTD·Filed 1982·Granted May 14, 1985·8 cites·18 claims
- 2360US4568686ASubstituted imidazoles and their useFARMOS OY·Filed 1981·Granted Feb 4, 1986·5 cites·17 claims
- 2459US6265421B1Phospholamban inhibitors and a method for increasing coronary flowORION CORP·Filed 1999·Granted Jul 24, 2001·21 cites·33 claims
- 2559US5498623A4(5) substituted imidazoles and their preparation and useORION YHTYMAE OY·Filed 1992·Granted Mar 12, 1996·15 cites·25 claims
- 2659US5439928AAromatase inhibiting 4(5)-imidazolesORION YHTYMAE OY·Filed 1993·Granted Aug 8, 1995·7 cites·27 claims
- 2757US5559141ASelective aromatase inhibiting 4(5)-imidazolesORION YHTYMAE OY·Filed 1992·Granted Sep 24, 1996·13 cites·24 claims
- 2856US6313311B1Imidazole derivatives having affinity for alpha2 receptorsORION CORP·Filed 1996·Granted Nov 6, 2001·14 cites·24 claims
- 2956US4684659AAntimypertensive substituted imidazolesFARMOS OY·Filed 1986·Granted Aug 4, 1987·5 cites·16 claims
- 3054US4933359A4(5)-substituted imidazole derivatives as α2 -adrenergic receptor blockersFARMOS OY·Filed 1987·Granted Jun 12, 1990·5 cites·9 claims
- 3151US7642279B2Atipamezole hydrochloride crystallization methodORION CORP·Filed 2006·Granted Jan 5, 2010·0 cites·11 claims
- 3251US6270628B1Method for detecting contamination and/or damage in a face running through a nip in a paper machine or in a paper finishing machineVALMET CORP·Filed 1998·Granted Aug 7, 2001·17 cites·20 claims
- 3348US5026868AIndenyl imidazolesFARMOS OY·Filed 1989·Granted Jun 25, 1991·3 cites·1 claims
- 3445US4556677AAlkane and alkene derivatives and their useFARMOS GROUP LTD·Filed 1982·Granted Dec 3, 1985·3 cites·26 claims
- 3544US5292887ASubstituted imidazole derivatives and their preparation and useFARMOS OY·Filed 1989·Granted Mar 8, 1994·3 cites·30 claims
- 3643US6615709B1Method for detecting contamination and/or damaging of a face that runs through a nip or nips in a calendar for paperMETSO PAPER INC·Filed 1998·Granted Sep 9, 2003·11 cites·11 claims
- 3743US6479530B2Imidazole derivatives having affinity for α2 receptorsORION CORP·Filed 2001·Granted Nov 12, 2002·0 cites·18 claims
- 3837US7425568B2Compounds, which are potent inhibitors of Na+ /Ca2+ exchange mechanism and are useful in the treatment of arrhythmiasORION CORP·Filed 2002·Granted Sep 16, 2008·0 cites·9 claims
- 3937US6362211B2Polycyclic indanylimidazoles with alpha2 adrenergic activityORION CORP·Filed 2001·Granted Mar 26, 2002·0 cites·16 claims
- 4034US7592350B2Polycyclic compounds as potent alpha2-adrenoceptor antagonistsORION CORP·Filed 2003·Granted Sep 22, 2009·0 cites·8 claims
- 4130US5962495ASelective aromatase inhibiting compoundsRISTO ARVO SAKARI LAMMINTAUSTA·Filed 1997·Granted Oct 5, 1999·2 cites·10 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →